Invention Grant
- Patent Title: Enzyme formulation for reducing histamine intolerance
-
Application No.: US15079404Application Date: 2016-03-24
-
Publication No.: US09849164B2Publication Date: 2017-12-26
- Inventor: Thea Fournier
- Applicant: Thea Fournier
- Agent Eric P. Mirabel
- Main IPC: A61K38/43
- IPC: A61K38/43 ; A61K38/54 ; A61K9/48

Abstract:
Disclosed is a formulation of the following enzymes: Alpha-galactosidase, Alpha amylase, Beta Glucanase, Lactase, BioCor DPP=IV (Proprietary blend) and Pectinase, which has been found to be effective in treating histamine intolerant people, and causing a significant improvement in a wide variety of pathologies and symptoms, including, but not limited to: inflammation, pruritus, urticaria, hypotension, tachycardia, fatigue, migraines, conjunctivitis, incontinence, nasal congestion, panic attacks, acid reflux, depression and angioedema.
Public/Granted literature
- US20170274056A1 Enzyme Formulation for Reducing Histamine Intolerance Public/Granted day:2017-09-28
Information query
IPC分类: